Breaking Finance News

zooplus (ETR:ZO1) target price raised to 148.00EUR, issued a report today by Hauck & Aufhäuser Privatbankiers KGaA

zooplus (ETR:ZO1) had its target price raised to 148.00EUR by Hauck & Aufhäuser Privatbankiers KGaA in a report released 9/22/2016. The new target price indicates a possible upside of 0.16% based on the company's last closing price.

Previously on 09/21/2016, Joh. Berenberg Gossler & Co. KG reported on zooplus (ETR:ZO1) raised the target price from 0.00EUR to 150.00EUR. At the time, this indicated a possible upside of 0.17%.

Yesterday zooplus (ETR:ZO1) traded 0.00% even at 128.05EUR. The company’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last closing price is up 0.00% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. 0 shares of zooplus traded, down from an avg. volume of 0

Performance Chart

zooplus (ETR:ZO1)

With a total market value of 0 EUR, zooplus has with a one year low of 0.00EUR and a one year high of 0.00EUR .

More About zooplus (ETR:ZO1)

Zooplus AG, also known as, is a Germany-based retailer of pet supplies. The Company markets products mainly through its online stores. The Company offers over 8000 products, including dry and wet pet food and food supplements, accessories, including toys, care products, and hygiene products, scratching posts, dog baskets. It sells food and accessories for dogs, cats, small animals, birds, reptiles, fish and horses and delivers the goods to approximately20 countries. The Company also provides a range of free content and information accessible through its Websites, such as veterinary and other animal-related advice, as well as interactive features, such as discussion forums and blogs. It operates through a number of subsidiaries, such as bitiba GmbH, matina GmbH, zooplus services Ltd, zooplus polska zoo, zooplus services ESP sl, zooplus france sarl, zooplus Pet Supplies and Trade Ltd, and zooplus italia Srl.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *